Latest News about AZN
Recent news which mentions AZN
   AstraZeneca Abandons Blood Cancer, Cardiovascular Programs Amid Portfolio Prioritization
   
  
  
  July 28, 2023
  From Benzinga
 From MarketWatch
 From Benzinga
 
   AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up
   
  
  
  July 28, 2023
  From Benzinga
 
   US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon
   
  
  
  July 28, 2023
  From Benzinga
 
   Earnings Scheduled For July 28, 2023
   
  
  
  July 28, 2023
  From Benzinga
 
   Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports
   
  
  
  July 26, 2023
  From Benzinga
 
   Dow Jones Leads Weekly Gains As Tesla, Netflix Sell-Offs Dent Nasdaq; Big Banks Show Resilience To Volatility
   
  
  
  July 21, 2023
  From Benzinga
 
   Why Pieris Pharmaceuticals Shares Shooting Higher Today?
   
  
  
  July 18, 2023
  From Benzinga
 From Benzinga
 
   AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants
   
  
  
  July 18, 2023
  From Benzinga
 From Benzinga
 
   3 Doomed Biotech Stocks Destined for Disaster
   
  
  
  July 17, 2023
  From InvestorPlace
 
   These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
   
  
  
  July 12, 2023
  From Benzinga
 From Benzinga
 
   What's Going On With Novavax (NVAX) Stock?
   
  
  
  July 10, 2023
  From Benzinga
 From Motley Fool
 From Benzinga
 Tickers 
   AZN
  
  
  From MarketWatch
 
   AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
   
  
  
  July 03, 2023
  From Benzinga
 
   Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the move
   
  
  
  July 03, 2023
  From MarketWatch
 
   4 Unparalleled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
   
  
  
  July 01, 2023
  From Motley Fool
 
   AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
   
  
  
  June 29, 2023
  From Benzinga
 From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


